CARCINOMA, HEPATOCELLULAR
Clinical trials for CARCINOMA, HEPATOCELLULAR explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, HEPATOCELLULAR trials appear
Sign up with your email to follow new studies for CARCINOMA, HEPATOCELLULAR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Drug combo vs standard therapy: which works better for liver cancer?
Disease control TerminatedThis study aimed to compare two treatment approaches for intermediate-stage liver cancer that can't be cured surgically. It tested whether a combination of two cancer drugs (regorafenib and pembrolizumab) works better than standard liver-directed treatments (TACE or TARE). The tr…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: PHASE3 • Sponsor: Translational Research in Oncology • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Tiny trial tests custom radiation doses for tough liver tumors
Disease control TerminatedThis study tested a personalized radiation treatment for adults with liver cancer that could not be removed by surgery. Doctors first gave a tiny 'scout' dose to see where it went, then calculated a custom therapeutic dose for each patient. The main goals were to check the treatm…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: NA • Sponsor: Imperial College London • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Scientists track immune cells during radiation to boost future treatments
Knowledge-focused TerminatedThis study aimed to understand how high-dose radiation therapy affects the immune system in cancer patients. Researchers followed 28 people with liver, colorectal, melanoma, or kidney cancers, taking blood samples before, during, and after their radiation treatments. The goal was…
Matched conditions: CARCINOMA, HEPATOCELLULAR
Phase: NA • Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:57 UTC